surpass 6 tirzepatide Frias_Tirzepatide: Overview of Trials in Patients With Type 2 Diabetes 💡SURPASS-6 Trial💡 Addition of Tirzepatide

Fact Sheet for Health Professionals: Choline

How Saxenda Works and Potential Interactions Saxenda contains liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes management and now licensed for weight management in adults with a body mass index (BMI) of 30 kg/m or greater, or 27 kg/m or greater with weight-related comorbidities

GLP-1 Weight Loss & Eligibility Calculator Your Details Estimated Potential Results (Semaglutide) Based on clinical studies showing 15-20% body weight loss over one year

Many patients lose 20% or more of their starting body weight, which represents a transformative result